Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Biomedit LLC has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 2 examiners and 2 art units, indicating separate examination channels within the same technology area. Counsel should maintain consistent descriptions of the inventive concept while preparing file-specific positions responsive to the different examination records.
DAUNER, JOSEPH G is the busiest examiner, with 1 pending matter. The examiner handles one identified action, while the other is assigned to a different examiner and art unit. Portfolio oversight should therefore combine shared technical review with separate tracking of each examiner’s objections, cited art, and response posture.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZEMAN, ROBERT A | 1 | 54.2% | +27.9% |
| DAUNER, JOSEPH G | 1 | 57.0% | +35.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694118 | Methods of Inhibiting Diseases Caused by Respiratory Viruses | ZEMAN, ROBERT A | — |
| 18694065 | METHODS FOR PRESERVING HEALTHY INTESTINAL MICROBIOME DURING GROWTH PROMOTER ADMINISTRATION | DAUNER, JOSEPH G | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694118 | Methods of Inhibiting Diseases Caused by Respiratory Viruses | ZEMAN, ROBERT A | — |
| 18694065 | METHODS FOR PRESERVING HEALTHY INTESTINAL MICROBIOME DURING GROWTH PROMOTER ADMINISTRATION | DAUNER, JOSEPH G | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694118 | Methods of Inhibiting Diseases Caused by Respiratory Viruses | ZEMAN, ROBERT A | 1645 | §103§112Other | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18694065 | METHODS FOR PRESERVING HEALTHY INTESTINAL MICROBIOME DURING GROWTH PROMOTER ADMINISTRATION | DAUNER, JOSEPH G | 1682 | §101§102§103 | Final Rejection | — | Pending | Mar 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBiomedit LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Robert A Zeman has the most, with 1 of Biomedit LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
